Consistent with these data, increased SYCP3 expression was also detected in another immunohistochemical analysis in NSCLC cases with lymph node metastasis (Kitano et al., 2017). The gene discussed is SYCP3; the disease is metastatic malignant neoplasm in the lymph nodes.